This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
30 Mar 2019  |  Global  |  Technology Research
Emerging Opportunities in Synthetic Biology Platforms
Synthetic Biology as a Profound Transformative Technology
Synthetic biology is being supported by a convergence of vanguard technologies. In the era of precision medicine and smart cities, synthetic biology plays a crucial role across multiple sectors and industries. Breakthrough technologies are facilitating the successful implementation of synthetic biology approaches, and also helping in addressing the...
$4,950.00 -
20 Mar 2019  |  North America  |  Market Research
2019 Predictions of the Global Life Sciences Industry
As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care
he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...
$1,500.00 -
11 Mar 2019  |  North America  |  Market Research
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...
$3,000.00 -
07 Mar 2019  |  North America  |  Market Research
Mergers and Acquisitions in the Global Life Sciences Industry, 2018
M&As for Growth in Patient Engagement, Artificial Intelligence and Big Data Analytics are Driving Greater Vertical Integration
The Healthcare industry has witnessed some of the largest mega-mergers in 2018 – mergers on the provider as well as the payer ends. While this has the potential to bring a shift in power centers in the ecosystem, each stakeholder has relied heavily on inorganic growth to maintain their stronghold. This Mergers and Acquisitions in Life Sciences In...
$3,000.00 -
13 Nov 2018  |  Global  |  Technology Research
Artificial Intelligence Revolutionizing the Pharmaceutical Industry
Optimal Synergy Between Leading-edge Computational Science and Therapeutics Development
The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...
$4,950.00 -
30 Oct 2018  |  Africa  |  Market Research
Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...
$1,500.00 -
04 Sep 2018  |  North America  |  Market Research
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...
$3,000.00 -
29 Jun 2018  |  Global  |  Technology Research
Novel Therapies for Rare and Genetic Diseases
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...
$4,950.00 -
06 Jun 2018  |  Global  |  Market Research
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of t...
$4,950.00 -
05 Jun 2018  |  Global  |  Market Research
Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022
Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum
The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treat...
$4,950.00